Search
項目搜尋
結構搜尋
Thermo Scientific Chemicals
DL-Phenylalanine, 99%
CAS: 150-30-1 | C9H11NO2 | 165.19 g/mol
Have Questions?
變更視圖
化學識別
CAS150-30-1
IUPAC Name2-amino-3-phenylpropanoic acid
Molecular FormulaC9H11NO2
InChI KeyCOLNVLDHVKWLRT-UHFFFAOYNA-N
SMILESNC(CC1=CC=CC=C1)C(O)=O
檢視更多
規格
規格表
規格表Appearance (Color)White
FormCrystals or powder or crystalline powder
Assay (Non-aqueous acid-base Titration)≥98.5 to ≤101.5%
DL-Phenylalanine is used to relieve cases of minor depression and other mood issues as well as and physical discomforts and pain. It is also used in acupuncture anesthesia, alcohol withdrawal.
This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.
Applications
DL-Phenylalanine is used to relieve cases of minor depression and other mood issues as well as and physical discomforts and pain. It is also used in acupuncture anesthesia, alcohol withdrawal.
Solubility
Soluble in water. Insoluble in ethyl ether, benzene.
Notes
Store away from strong oxidizing agents. Keep container tightly closed. Store in cool, dry conditions in well sealed containers.
DL-Phenylalanine is used to relieve cases of minor depression and other mood issues as well as and physical discomforts and pain. It is also used in acupuncture anesthesia, alcohol withdrawal.
Solubility
Soluble in water. Insoluble in ethyl ether, benzene.
Notes
Store away from strong oxidizing agents. Keep container tightly closed. Store in cool, dry conditions in well sealed containers.
RUO – Research Use Only
General References:
- David R. Wood; Fred W. Reimherr; Paul H. Wender. Treatment of attention deficit disorder with DL-phenylalanine. Psychiatry Research. 1985, 16,(1), 21-26.
- Tadakazu Tokumura; Masaki Nanbas; Yukl Tsushima; Kimio Tatsuishi; Masanori Kayano; Yoshiharu Machida; and Tsuneji Nagai. Enhancement of bioavailability of cinnarizine from its β-cyclodextrin complex on oral administration with dl-phenylalanine as a competing agent. J. Pharm. Sci. 1986, 75,(4), 391-394.